Literature DB >> 10403464

Detection and quantification of MUC7 in submandibular, sublingual, palatine, and labial saliva by anti-peptide antiserum.

J G Bolscher1, J Groenink, J S van der Kwaak, P A van den Keijbus, W van 't Hof, E C Veerman, A V Nieuw Amerongen.   

Abstract

The large carbohydrate moiety of low-Mr salivary mucin MUC7 (originally referred to as MG2) is subject to variations. Biochemical analysis and quantification of MUC7 in saliva samples require recognition tools that are independent of the carbohydrate moiety. Therefore, we have evoked three antisera to synthetic peptides of MUC7. One of these (CpMG2), raised against the C-terminal peptide, recognized native MUC7 in saliva and was characterized further. Recognition of MUC7 by CpMG2 turned out to be specific, resistant to dissociating and reductive treatments, and independent of glycosylation differences, as indicated by Western analysis and ELISA. The antiserum could be used to monitor MUC7 during purification procedures. MUC7 was demonstrated in small volumes of saliva from all (sero)mucous glands, including the palate and lip. Analysis with antibodies and lectins indicated large variations in amount as well as in glycosylation of MUC7. An ELISA was developed to determine the relative quantity of MUC7 in the glandular salivas: mean values of approximately 220, 980, and 100 microg mucin per mL were found in submandibular, sublingual, and palatine saliva, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403464     DOI: 10.1177/00220345990780071101

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  5 in total

1.  Evaluation of salivary mucins in children with deciduous and mixed dentition: comparative analysis between high and low caries-risk groups.

Authors:  Onauma Angwaravong; Waranuch Pitiphat; Jan G M Bolscher; Ponlatham Chaiyarit
Journal:  Clin Oral Investig       Date:  2015-02-18       Impact factor: 3.573

2.  Mucin-bacterial interactions in the human oral cavity and digestive tract.

Authors:  Muriel Derrien; Mark Wj van Passel; Jeroen Hb van de Bovenkamp; Raymond G Schipper; Willem M de Vos; Jan Dekker
Journal:  Gut Microbes       Date:  2010-06-23

3.  The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.

Authors:  Habtom H Habte; Anwar S Mall; Corena de Beer; Zoë E Lotz; Delawir Kahn
Journal:  Virol J       Date:  2006-11-24       Impact factor: 4.099

4.  Characterization of Oral Immunity in Cases and Close Household Contacts Exposed to Andes Orthohantavirus (ANDV).

Authors:  Constanza Martinez-Valdebenito; Camila Andaur; Jenniffer Angulo; Carolina Henriquez; Marcela Ferrés; Nicole Le Corre
Journal:  Front Cell Infect Microbiol       Date:  2020-11-03       Impact factor: 5.293

Review 5.  Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?

Authors:  Anwar Suleman Mall; Habtom Habte; Yolanda Mthembu; Julia Peacocke; Corena de Beer
Journal:  Virol J       Date:  2017-10-06       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.